Evidence map›Paper›PMID 41092360›Full record

ArticleBioinformatics (Oxford, England)2025

ZeroGEN: leveraging language models for zero-shot ligand design from protein sequences.

Yangyang Chen, Zixu Wang, Pengyong Li, Li Zeng, Xiangxiang Zeng, Lei Xu

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Yangyang ChenCollege of Computer Science and Electronic Engineering, Hunan University, Changsha, Hunan 410082, P.R. China.ORCID 0000-0002-3521-475X
Zixu WangCollege of Computer Science and Electronic Engineering, Hunan University, Changsha, Hunan 410082, P.R. China.
Pengyong LiSchool of Computer Science and Technology, Xidian University, Xian 710071, P.R. China.ORCID 0000-0001-5971-046X
Li ZengDepartment of AIDD, Shanghai Yuyao Biotechnology Co., Ltd., Shanghai 201109, P.R. China.
Xiangxiang ZengCollege of Computer Science and Electronic Engineering, Hunan University, Changsha, Hunan 410082, P.R. China.
Lei XuSchool of Electronic and Communication Engineering, Shenzhen Polytechnic University, Shenzhen 518055, P.R. China.ORCID 0000-0002-6440-6881

Funding

Beijing Natural Science Foundation L248013National Natural Science Foundation of China 62122025National Natural Science Foundation of China 62271329National Natural Science Foundation of China 62422113National Natural Science Foundation of China 62425204National Natural Science Foundation of China 62432011National Natural Science Foundation of China 62450002National Natural Science Foundation of China U22A2037Shenzhen Polytechnic University Research Fund 6022310036KShenzhen Polytechnic University Research Fund 6024310027KShenzhen Science and Technology 20231129091450002
6 · The paper itself

Abstract

motivationDeep generative methods based on language models have the capability to generate new data that resemble a given distribution and have begun to gain traction in ligand design. However, existing models face significant challenges when it comes to generating ligands for unseen targets, a scenario known as zero-shot learning. The ability to effectively generate ligands for novel targets is crucial for accelerating drug discovery and expanding the applicability of ligand design. Therefore, there is a pressing need to develop robust deep generative frameworks that can operate efficiently in zero-shot scenarios.

resultsIn this study, we introduce ZeroGEN, a novel zero-shot deep generative framework based on protein sequences. ZeroGEN analyzes extensive data on protein-ligand inter-relationships and incorporates contrastive learning to align known protein-ligand features, thereby enhancing the model's understanding of potential interactions between proteins and ligands. Additionally, ZeroGEN employs self-distillation to filter the initially generated data, retaining only the ligands deemed reliable by the model. It also implements data augmentation techniques to aid the model in identifying ligands that match unseen targets. Experimental results demonstrate that ZeroGEN successfully generates ligands for unseen targets with strong affinity and desirable drug-like properties. Furthermore, visualizations of molecular docking and attention matrices reveal that ZeroGEN can autonomously focus on key residues of proteins, underscoring its capability to understand and generate effective ligands for novel targets. AVAILABILITY AND IMPLEMENTATION: The source code and data of this work is freely available in the https://github.com/viko-3/ZeroGEN.

Indexed as

Drug DesignProteinsAlgorithmsDrug DiscoveryLigandsSoftwareLigandsProteins

Identifiers

PMID41092360
PMCPMC12596140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.